MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
152 hedge funds and large institutions have $819M invested in Merrimack Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 47
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
152
Holding in Top 10
1
Calls
$3.47M
Puts
$1.85M
Top Buyers
| 1 | +$34.5M | |
| 2 | +$25.4M | |
| 3 | +$24.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12M |
| 5 |
TA
Teachers Advisors
New York
|
+$11.7M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$6.15M | |
| 3 | -$5.35M | |
| 4 |
Renaissance Technologies
New York
|
-$2.89M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.57M |